SCHEMBL1965670

SCHEMBL1965670

C#CCNC1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.43
MAOB P27338 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DPP7 Q9UHL4 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
RECQL P46063 1/20 0.37
DPP4 P27487 1/20 0.37
PABPC1 P11940 1/20 0.36
HTT P42858 2/20 0.35
GLA P06280 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
BCHE P06276 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1355107 0.98 MAOA (0.42) MAOAMAOBKDM4EALDH1A1HSD17B10
SCHEMBL1962665 0.97
SCHEMBL4975898 0.92
SCHEMBL1744522 0.87
SCHEMBL22054129 0.79 MAOB (0.40) MAOAMAOBBCHEADRA2BADRA2C
SCHEMBL3631046 0.78 MAOB (0.46) MAOAMAOBBCHEADRA2BADRA2C
SCHEMBL20851289 0.78 BTK (0.41) MAOAMAOBRECQLDPP4ACHE
SCHEMBL16200857 0.76 KDM4E (0.40) KDM4EALDH1A1HSD17B10DPP7HRH3
SCHEMBL25784227 0.76 MAOA (0.41) MAOAMAOBALDH1A1DPP4TDP1
SCHEMBL27483239 0.76 GNAI3 (0.46) MAOAMAOBDPP7BCHEADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117160463-A Preparation method and application of cerium oxide supported copper-based catalyst 北京化工大学 2023-12-05 CN claimed
EP-3131994-B1 FAST CURING MIGRATION-FREE COMPOSITION BASED ON ORGANIC POLYMERS CONTAINING SILANE GROUPS SIKA TECH AG (CH) 2021-06-09 EP claimed
EP-3194503-B1 RADICALLY CURABLE SYNTHETIC RESIN COMPOSITION WITH OLIGOMERIC SILOXANE ADDITIVES. FISCHERWERKE GMBH & CO KG (DE) 2018-06-20 EP claimed
EP-2922893-B1 MOISTURE-CURING COMPOSITIONS, PROCESSES FOR PRODUCING SAME AND USE OF SAME EVONIK DEGUSSA GMBH (DE) 2016-04-06 EP claimed
EP-1304345-B1 Aminoalkylalkoxysiloxan containing mixtures , their preparation process and their use DEGUSSA (DE) 2005-12-14 EP claimed
EP-0997469-B1 Aminopropyl-functional siloxane oligomers DEGUSSA (DE) 2004-07-14 EP claimed
EP-0679945-B1 Processing of a silver halide photgraphic with a peroxide bleach composition EASTMAN KODAK CO (US) 1998-08-19 EP claimed
EP-0027028-B1 RUBBER STOPPER FOR SEALING ASAHI GLASS COMPANY LTD. (JP) 1983-06-15 EP claimed
US-20240051974-A1 DIRECT REDUCTIVE AMINATIONS WITH MONOTRIFLUOROACETOXY BORANE-AMINES PURDUE RESEARCH FOUNDATION (US) 2024-02-15 US disclosed
US-11289238-B2 Compositions for the filling of high aspect ratio vertical interconnect access (VIA) holes HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC (US) 2022-03-29 US disclosed
WO-2021112933-A1 COMPOSITIONS FOR THE FILLING OF HIGH ASPECT RATIO VERTICAL INTERCONNECT ACCESS (VIA) HOLES HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC (US) 2021-06-10 WO disclosed
US-20210174983-A1 COMPOSITIONS FOR THE FILLING OF HIGH ASPECT RATIO VERTICAL INTERCONNECT ACCESS (VIA) HOLES HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC 2021-06-10 US disclosed
CN-102365280-B adenosine receptor ligands and uses thereof DOMAIN THERAPEUTICS (FR) 2014-10-29 CN disclosed
CN-102365280-A Novel adenosine receptor ligands and uses thereof DOMAIN THERAPEUTICS 2012-02-29 CN disclosed
EP-1240283-B1 LUBRICATING COMPOSITION BASED ON SILOXANE, NOT RELEASING HYDROGEN, PREPARATION METHOD AND USE THEREOF RHODIA CHIMIE SA (FR) 2004-03-17 EP disclosed
US-20040006047-A1 Heterocyclic amides, a process for their preparation, compositions comprising them and their use MERIAL LIMITED 2004-01-08 US disclosed
EP-1250405-A1 SILOXANE-BASED LUBRICATING COMPOSITION, NOT RELEASING HYDROGEN, PREPARATION METHOD AND USE THEREOF RHODIA CHIMIE (FR) 2002-10-23 EP disclosed
EP-1240283-A1 LUBRICATING COMPOSITION BASED ON SILOXANE, NOT RELEASING HYDROGEN, PREPARATION METHOD AND USE THEREOF RHODIA CHIMIE (FR) 2002-09-18 EP disclosed
WO-2001044416-A1 SILOXANE-BASED LUBRICATING COMPOSITION, NOT RELEASING HYDROGEN, PREPARATION METHOD AND USE THEREOF RHODIA CHIMIE (FR) 2001-06-21 WO disclosed
WO-2001040417-A1 LUBRICATING COMPOSITION BASED ON SILOXANE, NOT RELEASING HYDROGEN, PREPARATION METHOD AND USE THEREOF RHODIA CHIMIE (FR) 2001-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006047-A1 Heterocyclic amides, a process for their preparation, compositions comprising them and their use CBR1, HCN1, SCN1A MAOA 2258/4885MAOB 2449/4885KDM4E 1596/4885
US-20240051974-A1 DIRECT REDUCTIVE AMINATIONS WITH MONOTRIFLUOROACETOXY BORANE-AMINES MAOB, BCAT2, AADAT MAOA 20/4885MAOB 1/4885KDM4E 1177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.